Gu X - Search Results

1

Effects of 3-HAA on HCC by Regulating the Heterogeneous Macrophages-A scRNA-Seq Analysis.

Xue C, Gu X, Zheng Q, Shi Q, Yuan X, Chu Q, Jia J, Su Y, Bao Z, Lu J, Li L. Xue C, et al. Among authors: gu x. Adv Sci (Weinh). 2023 Jun;10(16):e2207074. doi: 10.1002/advs.202207074. Epub 2023 Apr 4. Adv Sci (Weinh). 2023. PMID: 37013458 Free PMC article.

2

Immune checkpoint targeting TIGIT in hepatocellular carcinoma.

Zheng Q, Xu J, Gu X, Wu F, Deng J, Cai X, Wang G, Li G, Chen Z. Zheng Q, et al. Among authors: gu x. Am J Transl Res. 2020 Jul 15;12(7):3212-3224. eCollection 2020. Am J Transl Res. 2020. PMID: 32774695 Free PMC article. Review.

3

Mitochondrial Mechanisms of Necroptosis in Liver Diseases.

Xue C, Gu X, Li G, Bao Z, Li L. Xue C, et al. Among authors: gu x. Int J Mol Sci. 2020 Dec 23;22(1):66. doi: 10.3390/ijms22010066. Int J Mol Sci. 2020. PMID: 33374660 Free PMC article. Review.

4

Model based on five tumour immune microenvironment-related genes for predicting hepatocellular carcinoma immunotherapy outcomes.

Gu X, Guan J, Xu J, Zheng Q, Chen C, Yang Q, Huang C, Wang G, Zhou H, Chen Z, Zhu H. Gu X, et al. J Transl Med. 2021 Jan 6;19(1):26. doi: 10.1186/s12967-020-02691-4. J Transl Med. 2021. PMID: 33407546 Free PMC article.

5

The dual functions of the long noncoding RNA CASC15 in malignancy.

Gu X, Chu Q, Zheng Q, Wang J, Zhu H. Gu X, et al. Biomed Pharmacother. 2021 Mar;135:111212. doi: 10.1016/j.biopha.2020.111212. Epub 2021 Feb 1. Biomed Pharmacother. 2021. PMID: 33433353 Free article. Review.

6

TTN-AS1 as a potential diagnostic and prognostic biomarker for multiple cancers.

Zheng QX, Wang J, Gu XY, Huang CH, Chen C, Hong M, Chen Z. Zheng QX, et al. Biomed Pharmacother. 2021 Mar;135:111169. doi: 10.1016/j.biopha.2020.111169. Epub 2021 Feb 1. Biomed Pharmacother. 2021. PMID: 33433359 Free article. Review.

7

Progress and assessment of lncRNA DGCR5 in malignant phenotype and immune infiltration of human cancers.

Xue C, Chen C, Gu X, Li L. Xue C, et al. Among authors: gu x. Am J Cancer Res. 2021 Jan 1;11(1):1-13. eCollection 2021. Am J Cancer Res. 2021. PMID: 33520356 Free PMC article. Review.

8

HAND2-AS1: A functional cancer-related long non-coding RNA.

Gu X, Zheng Q, Chu Q, Zhu H. Gu X, et al. Biomed Pharmacother. 2021 May;137:111317. doi: 10.1016/j.biopha.2021.111317. Epub 2021 Feb 5. Biomed Pharmacother. 2021. PMID: 33556872 Free article. Review.

9

DLX6-AS1 is a potential biomarker and therapeutic target in cancer initiation and progression.

Zheng Q, Gu X, Yang Q, Chu Q, Dai Y, Chen Z. Zheng Q, et al. Among authors: gu x. Clin Chim Acta. 2021 Jun;517:1-8. doi: 10.1016/j.cca.2021.02.006. Epub 2021 Feb 17. Clin Chim Acta. 2021. PMID: 33607068 Review.

10

Transcription factor E2F4 is an indicator of poor prognosis and is related to immune infiltration in hepatocellular carcinoma.

Zheng Q, Fu Q, Xu J, Gu X, Zhou H, Zhi C. Zheng Q, et al. Among authors: gu x. J Cancer. 2021 Jan 21;12(6):1792-1803. doi: 10.7150/jca.51616. eCollection 2021. J Cancer. 2021. PMID: 33613768 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10,673 results

Search Page

Filters